Clinical trial

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who…

NCT00310180 · National Cancer Institute (NCI), NIH · Active, not recruiting

Key facts

NCT number NCT00310180
Title Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Official title Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment:The TAILORx Trial
Acronym TAILORx
Lead sponsor National Cancer Institute (NCI), NIH
Collaborators American College of Surgeons Cancer and Leukemia Group B NSABP Foundation Inc NCIC Clinical Trials Group North Central Cancer Treatment Group SWOG Cancer Research Network
Status Active, not recruiting
Phase Phase 3
Study type Interventional
Conditions Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIB Breast Cancer AJCC v7
Intervention type Drug, Other, Radiation
Interventions Anastrozole, Exemestane, Laboratory Biomarker Analysis, Letrozole, Quality-of-Life Assessment, Radiation Therapy, Tamoxifen Citrate
Enrollment 10,273
Start date Apr 7, 2006
Primary completion Mar 2, 2018
Completion Sep 30, 2030
First posted Apr 3, 2006
Last update posted Dec 5, 2025
Countries Australia, Canada, Ireland, New Zealand, Peru, Puerto Rico, United Kingdom, United States

At a glance

  • 1,000+ Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies